Zobrazeno 1 - 10
of 146
pro vyhledávání: '"T, Pulay"'
Autor:
P. Sutka, J. Csépli, R. Gimes, Ferenc Paulin, T. Pulay, V. Forgács, I. Kovács, M. Ziwe-El-Abidine, Bálint Nagy, F. Lindeisz, Csömör S
Publikováno v:
Mycoses. 32:463-468
Summary: The sera of 263 women — 217 infertile and 46 pregnant — were examined by various serological methods (precipitation test, agglutination, indirect immuno-fluorescence) to detect Candida guilliermondii var. guilliermondii (C.g.) infection.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e8c28be1348bae725a02a5883000981
https://doi.org/10.1111/j.1439-0507.1989.tb02283.x
https://doi.org/10.1111/j.1439-0507.1989.tb02283.x
Publikováno v:
Neoplasma. 49(2)
Oral antiemetics are seldom taken by patients (women, children or those having tumors of the buccal area, mouth or esophagus), who find it difficult to swallow. In addition to anatomical reasons, the side effects of cytostatics require medication. Fa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::254a754b80e37a71c5f8d6f6fc88c8a6
https://pubmed.ncbi.nlm.nih.gov/12088106
https://pubmed.ncbi.nlm.nih.gov/12088106
Publikováno v:
Orvosi hetilap. 142(42)
The authors summerize the results of second-line combination chemotherapy with paclitaxel (175 mg/m2, 3h) and carboplatin (AUC 5 mg/ml.min) in patients with recurrent epithelial ovarian cancer. The paclitaxel/carboplatin therapy was applied in 57 pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6f5633bef08a29f8b5adc342ad1c6c0c
https://pubmed.ncbi.nlm.nih.gov/11760646
https://pubmed.ncbi.nlm.nih.gov/11760646
Publikováno v:
Orvosi hetilap. 142(31)
Authors evaluated two forms of antiemetic therapy in 129 courses of 51 gynecological cancer patients treated with cisplatin chemotherapy of moderately or highly emetic dose (50-100 mg/m2) in a prospective, non randomized study. The patients received
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dfdc96e59ea7580e115f44fab5a8aed9
https://pubmed.ncbi.nlm.nih.gov/11556262
https://pubmed.ncbi.nlm.nih.gov/11556262
Publikováno v:
Orvosi hetilap. 142(27)
In a 2-year period, 136 HPV positive cytological samples of the cervix uteri were analyzed at the Department of Molecular Pathology, National Institute of Oncology, Hungary. Comparison with the international data obtained from the literature revealed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::05479edf3ea8c44a5a115c928ef6fa00
https://pubmed.ncbi.nlm.nih.gov/11481905
https://pubmed.ncbi.nlm.nih.gov/11481905
Publikováno v:
European journal of gynaecological oncology. 22(1)
Since premedication with H1, H2 receptor antagonists and steroids fewer side-effects of paclitaxel (PTXL) chemotherapy have been published. The authors summarize the literature and their own experience.23 patients with stage III ovarian cancer were t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::83cf1891f5b78c3b324f150b5dcb8f5b
https://pubmed.ncbi.nlm.nih.gov/11321504
https://pubmed.ncbi.nlm.nih.gov/11321504
Publikováno v:
Orvosi hetilap. 141(40)
Frequency and prognostic value of cell heterogeneity in FIGO 1a-2a cervical cancer was examined, in 66 of patients underwent Wertheim type hysterectomy between 1989 and 1995 in National Institute of Cancer, Budapest, Hungary. A newly developed DNA im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ea3a0889dc7851b9a1ded2bbc04d0684
https://pubmed.ncbi.nlm.nih.gov/11064570
https://pubmed.ncbi.nlm.nih.gov/11064570
Autor:
M, Van Der Looij, C, Szabo, I, Besznyak, G, Liszka, B, Csokay, T, Pulay, J, Toth, P, Devilee, M C, King, E, Olah
Publikováno v:
International journal of cancer. 86(5)
We have investigated the impact of BRCA1 and BRCA2 mutations that were frequently identified among Hungarian high-risk breast-ovarian cancer families (Ramus et al., 1997b, AJHG), on the development of breast and ovarian cancer in the general Hungaria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::95c26df5e5fddd17d33b24e08e271d8f
https://pubmed.ncbi.nlm.nih.gov/10797299
https://pubmed.ncbi.nlm.nih.gov/10797299
Autor:
S. Varga, J. Vízkeleti, T. Pulay, Csaba Polgár, Georgina Fröhlich, I. Vereczkey, I. Pete, Miklós Kásler
Publikováno v:
Radiotherapy and Oncology. 99:S266
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c417a82e413c6305d463748842078838
https://doi.org/10.1016/s0167-8140(11)70780-0
https://doi.org/10.1016/s0167-8140(11)70780-0
Publikováno v:
Oncology Research and Treatment. 4:22-28
Die naturliche zellvermittelte Zytotoxizitat (NCMC) menschlicher peripherer Lymphozyten gegen die allogene Tumorzellenlinie (K-562) wurde durch das AB-Serum bedeutend erhoht. Die fur die Erhohung verantwortliche Substanz war im Laufe der Dialyse bzw.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e03bc8baff99e003071ed8d8b5fe1ee
https://doi.org/10.1159/000214871
https://doi.org/10.1159/000214871